Accelerating Life Sciences R&D With Pega

  • Video
  • 03:20

Despite huge scientific advances and new technologies, biopharma R&D has been struggling for decades. The average annual output of approved new products per major pharmaceutical company had remained relatively flat for nearly 60 years – irrespective of the company’s size or level of R&D investment. Learn how industry leaders rely on Pega to change the game by connecting end-to-end lab data workflows, making clinical trials more efficient, reducing risk, and operationalizing quality management – to revolutionize R&D operations.


Related Resources

PegaWorld 2018 promo card

PegaWorld 2018

Registration is Now Open

Discover why 4,500 global leaders plan to join us next June in Las Vegas!

The Alternative


Don’t fall for the hype. See why today’s leading enterprises choose Pega CRM.